GRAIL, Inc. Basic Shares Outstanding (Weighted Average)
GRAIL, Inc. (GRAL) reported Basic Shares Outstanding (Weighted Average) of 43.11 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- GRAIL, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 43.11M shares, a 20.45% increase year-over-year.
- GRAIL, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 40.64M shares, a 18.46% increase year-over-year.
- GRAIL, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 40.77M shares, a 21.24% increase year-over-year.
- GRAIL, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 36.12M shares, a 13.31% increase year-over-year.
- GRAIL, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 36.75M shares, a 15.21% increase from fiscal 2024.
- GRAIL, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 31.90M shares, a 2.74% increase from fiscal 2023.
- GRAIL, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 31.05M shares, a 0.00% change from fiscal 2023.
- GRAIL, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 31.05M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 43.11M shares 10-Q · filed 2026-08-06 | 41.88M shares 10-Q · filed 2026-08-06 | 41.51M shares derived: average of 3 quarters · filed 2026-08-06 | 40.16M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 40.64M shares 10-Q · filed 2026-05-07 | 40.71M shares derived: average of 2 quarters · filed 2026-05-07 | 39.18M shares derived: average of 3 quarters · filed 2026-05-07 | 38.33M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 40.77M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 38.45M shares derived: average of 2 quarters · filed 2026-03-12 | 37.56M shares derived: average of 3 quarters · filed 2026-08-06 | 36.75M shares 10-K · filed 2026-03-12 |
| 2025-09-30 | 36.12M shares 10-Q · filed 2025-11-13 | 35.96M shares derived: average of 2 quarters · filed 2026-08-06 | 35.42M shares 10-Q · filed 2025-11-13 | 34.96M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 35.79M shares 10-Q · filed 2026-08-06 | 35.05M shares 10-Q · filed 2026-08-06 | 34.58M shares derived: average of 3 quarters · filed 2026-08-06 | 33.90M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 34.31M shares 10-Q · filed 2026-05-07 | 33.97M shares derived: average of 2 quarters · filed 2026-05-07 | 33.27M shares derived: average of 3 quarters · filed 2026-05-07 | 32.72M shares derived: average of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | 33.63M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 32.75M shares derived: average of 2 quarters · filed 2026-03-12 | 32.19M shares derived: average of 3 quarters · filed 2026-03-12 | 31.90M shares 10-K · filed 2026-03-12 |
| 2024-09-30 | 31.88M shares 10-Q · filed 2025-11-13 | 31.46M shares derived: average of 2 quarters · filed 2025-11-13 | 31.33M shares 10-Q · filed 2025-11-13 | 31.26M shares derived: average of 4 quarters · filed 2026-03-12 |
| 2024-06-30 | 31.05M shares 10-Q · filed 2025-08-13 | 31.05M shares 10-Q · filed 2025-08-13 | 31.05M shares derived: average of 3 quarters · filed 2026-03-12 | 31.05M shares derived: average of 4 quarters · filed 2026-03-12 |
| 2024-03-31 | 31.05M shares 10-Q · filed 2025-05-14 | 31.05M shares derived: average of 2 quarters · filed 2026-03-12 | 31.05M shares derived: average of 3 quarters · filed 2026-03-12 | 31.05M shares derived: average of 4 quarters · filed 2026-03-12 |
| 2023-12-31 | 31.05M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 31.05M shares derived: average of 2 quarters · filed 2026-03-12 | 31.05M shares derived: average of 3 quarters · filed 2026-03-12 | 31.05M shares 10-K · filed 2025-03-05 |
| 2023-10-01 | 31.05M shares 10-Q · filed 2024-11-13 | 31.05M shares derived: average of 2 quarters · filed 2024-11-13 | 31.05M shares 10-Q · filed 2024-11-13 | |
| 2023-06-30 | 31.05M shares 10-Q · filed 2024-08-13 | 31.05M shares 10-Q · filed 2024-08-13 | ||
| 2023-01-01 | 31.05M shares 10-K · filed 2025-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |